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ABSTRACT
Purpose: Chlorhexidine is a good prophylactic agent for post-extraction dry socket alveolitis. The bio-adhesive 0.2% chlorhexi-
dine gel could improve this action since its intra-alveolar positioning would allow a more direct action on the alveolus and more 
prolonged action of the medication.
Materials and Method: We present a single blind, randomised study on 30 patients to evaluate the efficacy of the bio-adhesive 
0.2% chlorhexidine gel, placed only once within the alveolus, on the reduction of the incidence of impacted third molar post-
extraction dry socket alveolitis and its post-operative effects on patients.
Results. A reduction of 42.65% in the occurrence of alveolitis and a more favourable post-operative period in the experimental group 
was observed. In the control group, the appearance of alveolitis was 30.76% opposite to 17.64 % in the experimental group.
Conclusions: The bio-adhesive 0.2% chlorhexidine gel, applied only once after the extraction of impacted third molars, 
seems to be an appropriate option for the reduction of alveolitis. It improves the buccal aperture and oedema in the 
post-operative period, although further double blind studies with larger samples are necessary.   
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RESUMEN
Introducción: La clorhexidina es un buen agente profiláctico de la alveolitis post-extracción. La aparición del gel bioadhe-
sivo conteniendo clorhexidina al 0,2% podría mejorar esta acción. Su colocación intraalveolar permitiría una actuación 
más directa sobre el alveolo y una actuación más prolongada del fármaco.
Pacientes y método: Presentamos un estudio a simple ciego, randomizado, sobre 30 pacientes, valorando la influencia de 
la colocación en una sola vez y de forma intraalveolar gel bioadhesivo conteniendo clorhexidina al 0,2% tras la extracción 
de terceros molares incluidos, en la aparición de alveolitis y en el postoperatorio de los pacientes.
Resultados: Encontramos una reducción del 42,65% en la tasa de alveolitis y un postoperatorio más favorable en el grupo 
experimental. En el grupo control, la alveolitis apareció en un 30,76% frente a un 17,64 % en el grupo experimental.
Discusión y conclusiones: Tras comparar nuestros datos con otros estudio, pensamos que el gel bioadhesivo de clorhexi-
dina al 0,2%, aplicado en una sola vez de forma intraalveolar parece ser una opción adecuada para la prevención de 
la alveolitis. Esta actuación mejora la apertura bucal y el edema en el postoperatorio, aunque son necesarios nuevos 
estudios realizados a doble ciego y con muestras más amplias para confirmar nuestros datos. 
Palabras clave: Osteitis alveolar, alveolitis seca, extracción de tercer molar, clorhexidina, estudio piloto.
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INTRODUCTION
Dry socket alveolitis is a post-extraction complication 
which can be defined as a postoperative pain in and around 
the extraction site, which increases in severity at any time 
between 1 and 3 days after the extraction accompanied by 
a partially or totally disintegrated blood clot within the 
alveolar socket with or without halitosis (1). Its frequency 
varies from 1% to 70%. The incidence of alveolitis after the 
extraction of impacted third molars is high, between 20-30% 
of extractions (2-6). 
It may be a self-limiting pain, but it does cause conside-
rable problems in patients. Antibiotics are efficient in the 
prevention of alveolitis but they are expensive and generate 
resistances, thus justifying the research of new treatments 
which will give similar results with less cost and less undesi-
rable effects (7-9). The introduction of 0.2% chlorhexidine 
in the form of a bio-adhesive gel has opened up new lines 
of investigation. The presentation of the bio-adhesive gel 
is such that it could be placed within the alveolus, making 
it possible to have a more direct action on the alveolus, and 
prolonging the time of the chlorhexidine treatment, in com-
parison to mouthwash which has been the pharmaceutical 
form used in other published clinical studies. 
The intention of this paper is to present the data obtained in 
a pilot study carried out to evaluate the efficacy of the bio-
adhesive 0.2% chlorhexidine gel, placed within the alveolus 
only once, on the reduction of the incidence of dry socket 
alveolitis after the extraction of impacted third molars and 
its post-operative influence on patients.
MATERIALS AND METHODS
The study was carried out at the Faculty of Odontology 
of the University of Seville (Spain). The design of the in-
vestigation work consisted of a pilot study on 30 patients 
carried out using methods for a prospective, parallel, single 
blind clinical trial. The medication and the doses studied 
were 10ml of gel containing 0.2% chlorhexidine digluconate 
and administered topically (intra-alveolar) versus a con-
trol treatment which consisted of not administrating any 
intra-alveolar medication. The principles of the Helsinki 
Declaration were followed and informed consent has been 
obtained. 
The subjects studied were patients of both sexes, included 
consecutively, between 18 and 60 years, who presented with 
one or two lower impacted wisdom teeth with a difficulty 
index of between 4 and 7 on a scale of 0 to 10 according to 
Koerner (10), who had no symptoms ten days presurgery, 
and its extraction was indicated. The exclusion criteria 
for this study were the following: patients with contra-in-
dications for intervention, patients with AIDS; smoking 
patients; immuno-depressed; pregnancy or women in the 
lactating period or using oral contraceptives; allergy to 
chlorhexidine, lidocaine or paracetamol; patients who 
required the extraction of two wisdom teeth at once, with 
any bone pathology or had ingested any medication 4 days 
before the operation. 
The independent variable was the placing or not of the bio-
adhesive gel containing 0.2% chlorhexidine in the alveolus 
after the extraction of the impacted wisdom tooth. The 
extraction was carried out following the same technique: 
anaesthesia with two cartridges of 2% lidocaine combined 
with epinephrine, in the lower alveolar nerve and lingual 
nerve at the level of the spine of Spyx and the buccal nerve, 
at the level of the bottom of the vestibule. A bayonet incision 
was performed, osteotomy of the bone and when it was ne-
cessary dental section was carried out before its extraction. 
After curettage of the alveolus, an envelope was opened, 
in which it indicated whether the patient should receive the 
bio-adhesive gel or not. The aforementioned allocation into 
one group or another was carried out by computer before 
the start of the study. The patients were not told whether 
they received the bio-adhesive gel or not (single blind). 
All the patients took, as post-operative treatment, 14.05mg 
codeine phosphate and 500mg of paracetamol on demand, 
the number of pills taken each day during the first week 
were registered in the data collection notebook.  Before the 
intervention, the buccal aperture and the pain with which 
the patient presented were registered on a verbal scale of 
1 to 5. On the third and the seventh post-operative day the 
buccal aperture was measured again (with a gauge).  Facial 
edema as well as the pain was evaluated daily on a visual 
analogue scale (VAS) of 0 to 100mm during the first week 
post-operative. We made a metric register of the edema, 
marking on the face of the patient the following points: man-
dibular angle, lateral cantus, base of the nasal wing, nasal 
commissures and pogonion on the side of the intervention. 
Taking the mandibular angle as a reference, we measured 
the distance between this point and the rest of the marks 
(11). The sum of all the measures was the facial size for that 
day. This measurement was carried out before the surgical 
procedure and the third and last day of follow up.  The main 
variable was evaluated as, whether post-operative alveolitis 
appeared or not, using the diagnostic criteria specified by 
Blum (1): postoperative pain in and around the extraction 
site, which increases in severity at any time between 1 and 
3 days after the extraction accompanied by a partially or 
totally disintegrated blood clot within the alveolar socket 
with or without halitosis. The tolerance to the treatment, on 
a verbal scale of one to five, was also evaluated.
The chi squared test was applied for the comparison of the 
proportions and the Student t test for the comparison of 
the means between the two groups.
RESULTS
The control group consisted of 13 patients, with 17 in the 
experimental group. All completed the protocol. There were 
30 impacted wisdom tooth extractions (14 left and 16 right) 
from September to December 2001. The mean age of the 
sample was 27.8 years (Standard Deviation, SD = 8.63 years), 
and 21 women and 9 men were treated. The mean difficulty 
was 5.23 (SD = 1.07) using the Koerner scale (10). There 
were no significant differences between the difficulty of the 
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extractions in the control and experimental group. The data 
as regards sex, mean age, right and left lower wisdom tooth 
and difficulty by group are shown in Table 1. No significant 
differences were found between the two groups, before treat-
ment, as regards facial size, pain and buccal aperture.
In relation to the incidence of alveolitis –the primary aim 
of this study-, we detected the appearance of 4 cases of 
alveolitis (30.76%), whilst in the experimental group, 3 
(17.64%) were found (no statistically significant difference, 
power of test of 13.57%). 
The data referring to the pain suffered by the patients in 
the first week post-operative and the mean of the number 
of tablets taken each day did not produce any significant 
differences (Tables 1 and 2, Figure 1). The data regarding 
the buccal aperture and the facial size on the third and the 
eighth day post-operative are seen in Table 3. The data as 
regards the facial edema in the first week post-operative 
are shown in Table 2 and in Figure 1. No adverse effects 
were presented and the patients adequately tolerated the 
treatment carried out (Table 3).   
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Table 1. Data  relative to sex, mean age, tooth extracted, difficulty of extraction, facial size, pain (VAS) and buccal aperture before treatment, 
by groups. (SD=Standard Deviation)
Table 2. The  pain and edema data in the first week post-operative (VAS scale). (SD=Standard Deviation) (*=statistically significant 
difference; p < 0.05; Student t ).
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Facial Size Buccal aperture 
 Tolerance 
(1 to 5) 3º day after 
extraction 
8º day after 
extraction 
3º day after 
extraction 
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Table 3. Data of facial size and buccal aperture on the third and last day of follow up, as well as the number of analgesic pills taken per day 
and tolerance to the treatment carried out (verbal scale of 1 (totally tolerable) to 5 (totally intolerable). (SD=Standard Deviation)
Fig. 1. Graph of the pain and oedema data in the first week post-operative. * = statistically significant differ-
ence (p<0.05). 
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DISCUSSION
The etiology of alveolitis is not known, therefore its pre-
vention is fundamental. Different etiopathological theories 
exist, the main ones being fibrinolytic and bacterial (2-6, 
12). Numerous medications have been used in its preven-
tion. Anti-fibrinolytic agents, saline mouthwashes (7,13), 
tranquiliser dressings (14) and polylactic acid (15), have 
been applied with some success. However, the most effective 
have been the antiseptics and antibiotics, especially tetra-
cycline, both systemically and locally (8,9). Despite the fact 
that some antibiotics produce a decrease in the incidence 
of alveolitis, their high cost, their significant side effects 
and the possibility of generating resistances limit their use. 
Among the antiseptics, chlorhexidine has shown to be a 
good prophylactic agent of dry socket alveolitis. In a study 
carried out by Ragno and Szkutnik (4), 0.2% chlorhexidine 
digluconate mouthwash produced a reduction of alveolar 
osteitis after extraction of impacted third molars (17.5% as 
opposed to 36% in a control group).
In the literature there is no published clinical trial similar 
to ours which has used the chlorhexidine bio-adhesive gel 
placed in the alveolus as a study drug for the prevention 
of alveolitis after the extraction of impacted third molars. 
Therefore, we can only compare our study with other trials 
of other products and other presentations of chlorhexidine. 
Neither have we found articles with which to compare our 
buccal aperture, facial size and complexity of extraction 
data.   
The number of patients studied, although very small to 
find statistically significant differences, is sufficient to draw 
conclusions, although only in a preliminary manner, pending 
studies with much larger series. In other published studies 
the numbers of patients included were between 20 and 67 
per group, as opposed to 13 and 17 in this study (2-4,16,17). 
The mean age of our patients was 27.8 years. Other studies 
have a mean patient age of studied patients less than in 
our study (17-19). With respect to the proportion of males 
and females (30% men – 70% women), other studies also 
refer to a proportion of 1:2 in favour of women (17-19). 
Others were found were both sexes were balanced (3,16,20). 
We did not control tobacco nor oral contraceptives use in 
our patients, but these variables will have to be taken into 
account in next works.
The incidence of  alveolitis was low in the experimental 
group, which was clinically significant in respect to the 
control group (reduction of 42.65%). Delibalsi et al. (16) 
found similar percentages of alveolitis using mouthwashes 
of saline and 0.2% chlorhexidine (20.9% versus 23.7%). The 
percentage found when a mouthwash of chlorhexidine with 
amoxicillin-clavulanate was 8.9%. In the study by Berwick 
and Lessin (2) they found no differences in the incidence of 
alveolitis in the groups under study (chlorhexidine 0.12% 
and cetylpyridium 0.05%).
Larsen (3) found 16% of alveolitis in the control group 
(placebo), whilst 8% was obtained in the experimental 
group (mouthwash with 0.12% chlorhexidine for one week 
post-extraction). Ragno and Szkutnik (4) obtained a re-
duction of 50 % using the same study groups. Bonine (18) 
and Hermesch et al (19), also found reductions in alveolitis 
of around 50% using 0.12% chlorhexidine mouthwashes. 
These reductions are slightly higher than those found in 
our study (42.65%). 
We have found no significant differences in respect to facial 
size, although we did detect statistically significant differen-
ces in facial oedema in the last days of the follow up (Table 
2). This concurred with other authors who referred to a bet-
ter recovery in the experimental group (21-23), although in 
their studies this improvement was more significant. Perhaps 
the form of application or the fact that the medication was 
deposited more than once could be the explanation. 
In respect to the buccal aperture and pain experienced, no 
significant differences were found. No secondary effects 
were seen that had been referred to in other similar studies 
(16). Nor was any adverse effect detected.  
In summary, the data presented indicates that the bio-
adhesive gel containing 0.2% chlorhexidine, applied only 
once, post-extraction in the alveolus, decreased alveolitis 
in a percentage similar to that achieved in other studies 
(2,16,18,20,24). The use of  the experimental treatment 
produced a better patient recovery, especially with refe-
rence to the buccal aperture and post-extraction edema. 
Unfortunately, the sample size and the lack of statistical 
differences limit the conclusions that could reach this study. 
In this respect, this preliminary data should be corroborated 
by further studies applying a double blind protocol and a 
larger sample size.
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